Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Sales | 27,179 | 30,113 | 28,213 | 27,333 | 26,586 |
| Cost of Goods | 15,532 | 18,903 | 16,127 | 14,450 | 14,631 |
| Gross Profit | 11,648 | 11,210 | 12,086 | 12,883 | 11,956 |
| Operating Expenses | 8,247 | 8,508 | 7,186 | 6,120 | 6,078 |
| Operating Income | 3,401 | 2,702 | 4,900 | 6,763 | 5,877 |
| Interest Expense | 498 | 608 | 805 | 938 | 1,019 |
| Other Income | -83 | -53 | 447 | -33 | -129 |
| Pre-tax Income | 2,820 | 2,041 | 4,541 | 5,792 | 4,729 |
| Income Tax | 1,157 | 1,001 | 1,227 | 1,650 | 1,415 |
| Net Income Continuous | 1,663 | 1,040 | 3,314 | 4,142 | 3,315 |
| Net Income | $1,663 | $1,040 | $3,314 | $4,142 | $3,315 |
| EPS Basic Total Ops | 0.02 | 0.01 | 0.03 | 0.05 | 0.04 |
| EPS Basic Continuous Ops | 0.02 | 0.01 | 0.03 | 0.05 | 0.04 |
| EPS Diluted Total Ops | 0.02 | 0.01 | 0.03 | 0.04 | 0.04 |
| EPS Diluted Continuous Ops | 0.02 | 0.01 | 0.03 | 0.04 | 0.04 |
| EBITDA(a) | $4,627 | $4,230 | $7,578 | $7,995 | $7,383 |